”We intend to build the HiOwna brand into a Rs 100-crore business”
Recently, the Himalaya Drug Company launched 'HiOwna-Jr' flagging its entry into the nutraceutical and dietary supplement market.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SC hearing of Novartis patent case re-scheduled for August 22
Postponement due to a request from lawyers representing Novartis
AIOCD to support market-based pricing formula based on all-brands
Likely to address patient needs and balance industry growth
Astrazeneca and Cellworks collaborate to find new treatment for tuberculosis
It will pave the way for the creation of platforms and approaches to handle Multi Drug Resistant Tuberculosis
Mylan confirms first-to-file patent challenge relating to Pristique tablets
Pfizer, Wyeth, Wyeth Pharmaceuticals, and PF Prism CV sues Mylan
Natco Pharma and Mylan to appeal against US court ruling on Teva’s Copaxone
The decision by the US court covers several patents for the chemical composition of Copaxone
Provepharm signs three new distribution agreements in Europe
Agreement will cover eight additional European countries
Pharma M&A activity witnesses significant decline in volume
Asia Pacific sees highest fall in M&A activity in volume terms in June 2012, according to the Datamonitor-MedTRACK database…
DIA’s to host IT Life Sciences Summit
Summit on September 6-7, 2012 in Mumbai to focus on technology-enabled pharmaceutical business transformation